DrugDashboards

Sodium Acetate

Sodium Acetate · SODIUM ACETATE 4 meq/100mL · Injection, Solution, Concentrate · Intravenous · Fresenius Kabi USA, LLC

NDC 63323-0032-00 · 20 VIAL, PHARMACY BULK PACKAGE in 1 TRAY / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.0964per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$173.54per package of 2X100MLFresenius Kabi, LLC · May 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$176.20
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$418,318
1,536 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $88.80 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA206687
TE code
AP
Approval date
Oct 30, 2017
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)Mar 23, 2016
    month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)Mar 23, 2016
    month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)Feb 3, 2016
    Other
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

  • Class I · TerminatedMar 4, 2022
    Fresenius Kabi USA, LLC — Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

Manufacturers of Sodium Acetate (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Hospira, Inc.SODIUM ACETATE ANHYDROUS 164 mg/mLJul 15, 2026Sep 3, 2026
Milla Pharmaceuticals Inc.SODIUM ACETATE 164 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM ACETATE 4 meq/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.SODIUM ACETATE ANHYDROUS 3.28 g/20mLJul 15, 2026Aug 31, 2026
Amneal Pharmaceuticals Private LimitedSODIUM ACETATE ANHYDROUS 164 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Acetate — NDC 63323-0032-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63323003200.

Free to cite with attribution — see how the data is put together.